BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 31949278)

  • 1. Clinical relevance of somatic mutations in main driver genes detected in gastric cancer patients by next-generation DNA sequencing.
    Nemtsova MV; Kalinkin AI; Kuznetsova EB; Bure IV; Alekseeva EA; Bykov II; Khorobrykh TV; Mikhaylenko DS; Tanas AS; Kutsev SI; Zaletaev DV; Strelnikov VV
    Sci Rep; 2020 Jan; 10(1):504. PubMed ID: 31949278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CDH1 somatic alterations in Mexican patients with diffuse and mixed sporadic gastric cancer.
    Bustos-Carpinteyro AR; Oliveira C; Sousa A; Oliveira P; Pinheiro H; Carvalho J; Magaña-Torres MT; Flores-Miramontes MG; Aguilar-Lemarroy A; Jave-Suárez LF; Peregrina-Sandoval J; Cruz-Ramos JA; Sánchez-López JY
    BMC Cancer; 2019 Jan; 19(1):69. PubMed ID: 30642281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. THE STUDY OF THE EXPRESSION OF CDH1, KI67, P53 AND HER2 IN DIFFUSE GASTRIC CARCINOMA.
    Muzashvili T; Tutisani A; Chabradze G; Beridze N; Museridze N
    Georgian Med News; 2020 Feb; (299):147-150. PubMed ID: 32242863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CDH1 mutations in gastric cancers are not associated with family history.
    Choi S; Jang J; Heo YJ; Kang SY; Kim ST; Lee J; Kang WK; Kim JW; Kim KM
    Pathol Res Pract; 2020 May; 216(5):152941. PubMed ID: 32241597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Germline CDH1 mutations are a significant contributor to the high frequency of early-onset diffuse gastric cancer cases in New Zealand Māori.
    Hakkaart C; Ellison-Loschmann L; Day R; Sporle A; Koea J; Harawira P; Cheng S; Gray M; Whaanga T; Pearce N; Guilford P
    Fam Cancer; 2019 Jan; 18(1):83-90. PubMed ID: 29589180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic analysis of a case of Helicobacter pylori-uninfected intramucosal gastric cancer in a family with hereditary diffuse gastric cancer.
    Funakoshi T; Miyamoto S; Kakiuchi N; Nikaido M; Setoyama T; Yokoyama A; Horimatsu T; Yamada A; Torishima M; Kosugi S; Yamada H; Sugimura H; Haga H; Sakai Y; Ogawa S; Seno H; Muto M; Chiba T
    Gastric Cancer; 2019 Jul; 22(4):892-898. PubMed ID: 30542785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel Variants and Copy Number Variation in CDH1 Gene in Iranian Patients with Sporadic Diffuse Gastric Cancer.
    Moridnia A; Tabatabaiefar MA; Zeinalian M; Minakari M; Kheirollahi M; Moghaddam NA
    J Gastrointest Cancer; 2019 Sep; 50(3):420-427. PubMed ID: 29577179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutational landscape of gastric cancer and clinical application of genomic profiling based on target next-generation sequencing.
    Cai H; Jing C; Chang X; Ding D; Han T; Yang J; Lu Z; Hu X; Liu Z; Wang J; Shang L; Wu S; Meng P; Lin L; Zhao J; Nie M; Yin K
    J Transl Med; 2019 Jun; 17(1):189. PubMed ID: 31164161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sporadic Early-Onset Diffuse Gastric Cancers Have High Frequency of Somatic CDH1 Alterations, but Low Frequency of Somatic RHOA Mutations Compared With Late-Onset Cancers.
    Cho SY; Park JW; Liu Y; Park YS; Kim JH; Yang H; Um H; Ko WR; Lee BI; Kwon SY; Ryu SW; Kwon CH; Park DY; Lee JH; Lee SI; Song KS; Hur H; Han SU; Chang H; Kim SJ; Kim BS; Yook JH; Yoo MW; Kim BS; Lee IS; Kook MC; Thiessen N; He A; Stewart C; Dunford A; Kim J; Shih J; Saksena G; Cherniack AD; Schumacher S; Weiner AT; Rosenberg M; Getz G; Yang EG; Ryu MH; Bass AJ; Kim HK
    Gastroenterology; 2017 Aug; 153(2):536-549.e26. PubMed ID: 28522256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. E-Cadherin (CDH1) and p53 rather than SMAD4 and Caspase-10 germline mutations contribute to genetic predisposition in Portuguese gastric cancer patients.
    Oliveira C; Ferreira P; Nabais S; Campos L; Ferreira A; Cirnes L; Alves CC; Veiga I; Fragoso M; Regateiro F; Dias LM; Moreira H; Suriano G; Machado JC; Lopes C; Castedo S; Carneiro F; Seruca R
    Eur J Cancer; 2004 Aug; 40(12):1897-903. PubMed ID: 15288293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-throughput mutation profiling identifies novel molecular dysregulation in high-grade intraepithelial neoplasia and early gastric cancers.
    Fassan M; Simbolo M; Bria E; Mafficini A; Pilotto S; Capelli P; Bencivenga M; Pecori S; Luchini C; Neves D; Turri G; Vicentini C; Montagna L; Tomezzoli A; Tortora G; Chilosi M; De Manzoni G; Scarpa A
    Gastric Cancer; 2014; 17(3):442-9. PubMed ID: 24272205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of c.1531C>T Pathogenic Variant in the
    Norero E; Alarcon MA; Hakkaart C; de Mayo T; Mellado C; Garrido M; Aguayo G; Lagos M; Torres J; Calvo A; Guilford P; Corvalan AH
    Int J Mol Sci; 2019 Oct; 20(20):. PubMed ID: 31600923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Searching for E-cadherin gene mutations in early onset diffuse gastric cancer and hereditary diffuse gastric cancer in Korean patients.
    Kim S; Chung JW; Jeong TD; Park YS; Lee JH; Ahn JY; Kim DH; Choi KD; Lee W; Song HJ; Lee GH; Chun S; Jung HY; Min WK; Kim JH
    Fam Cancer; 2013 Sep; 12(3):503-7. PubMed ID: 23264079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Initial and crucial genetic events in intestinal-type gastric intramucosal neoplasia.
    Rokutan H; Abe H; Nakamura H; Ushiku T; Arakawa E; Hosoda F; Yachida S; Tsuji Y; Fujishiro M; Koike K; Totoki Y; Fukayama M; Shibata T
    J Pathol; 2019 Apr; 247(4):494-504. PubMed ID: 30474112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An α-E-catenin (CTNNA1) mutation in hereditary diffuse gastric cancer.
    Majewski IJ; Kluijt I; Cats A; Scerri TS; de Jong D; Kluin RJ; Hansford S; Hogervorst FB; Bosma AJ; Hofland I; Winter M; Huntsman D; Jonkers J; Bahlo M; Bernards R
    J Pathol; 2013 Mar; 229(4):621-9. PubMed ID: 23208944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene mutations in stool from gastric and colorectal neoplasia patients by next-generation sequencing.
    Youssef O; Sarhadi V; Ehsan H; Böhling T; Carpelan-Holmström M; Koskensalo S; Puolakkainen P; Kokkola A; Knuutila S
    World J Gastroenterol; 2017 Dec; 23(47):8291-8299. PubMed ID: 29307989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accuracy of Hereditary Diffuse Gastric Cancer Testing Criteria and Outcomes in Patients With a Germline Mutation in CDH1.
    van der Post RS; Vogelaar IP; Manders P; van der Kolk LE; Cats A; van Hest LP; Sijmons R; Aalfs CM; Ausems MG; Gómez García EB; Wagner A; Hes FJ; Arts N; Mensenkamp AR; van Krieken JH; Hoogerbrugge N; Ligtenberg MJ
    Gastroenterology; 2015 Oct; 149(4):897-906.e19. PubMed ID: 26072394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Somatic mutations and deletions of the E-cadherin gene predict poor survival of patients with gastric cancer.
    Corso G; Carvalho J; Marrelli D; Vindigni C; Carvalho B; Seruca R; Roviello F; Oliveira C
    J Clin Oncol; 2013 Mar; 31(7):868-75. PubMed ID: 23341533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CDH1 gene mutation in early-onset, colorectal signet-ring cell carcinoma.
    Aitchison A; Hakkaart C; Whitehead M; Khan S; Siddique S; Ahmed R; Frizelle FA; Keenan JI
    Pathol Res Pract; 2020 May; 216(5):152912. PubMed ID: 32147272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heterogeneous mutational profile and prognosis conferred by TP53 mutations in appendiceal mucinous neoplasms.
    Zhu X; Salhab M; Tomaszewicz K; Meng X; Mathew C; Bathini V; Switzer B; Walter O; Cosar EF; Wang X; Lambert LA; Hutchinson LM
    Hum Pathol; 2019 Mar; 85():260-269. PubMed ID: 30458197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.